Nath Bio-Genes (India) Limited

Symbol: NATHBIOGEN.NS

NSE

204.35

INR

Market price today

  • 9.5958

    P/E Ratio

  • -0.0434

    PEG Ratio

  • 3.88B

    MRK Cap

  • 0.02%

    DIV Yield

Nath Bio-Genes (India) Limited (NATHBIOGEN-NS) Stock Price & Analysis

Shares Outstanding

19M

Gross Profit Margin

0.53%

Operating Profit Margin

0.15%

Net Profit Margin

0.12%

Return on Assets

0.00%

Return on Equity

0.07%

Return on Capital Employed

0.00%

Company general description and statistics

Sector: Basic Materials
Industry: Agricultural Inputs
CEO:Mr. Satish Kagliwal
Full-time employees:433
City:Aurangabad
Address:Nath House
IPO:2014-01-28
CIK:

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers seeds for cereals, such as maize, paddy, millet, wheat, and jowar; fruit seeds; fiber and oil seeds, including cotton and mustard; and seeds for vegetables comprising chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet peeper, green paeas, pumpkin, tinda, cabbage, and French beans. It also provides crop protection supplements, such as WINPro GOLii, WINall, and Win Chi Win growth enhancer; and forage supplements, including NUTRIMAX GOLD and NUTRIMAX for enhanced fodder yields. The company offers its products through a network of distributors, dealers, and processing plants. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.

General Outlook

In simple terms, Nath Bio-Genes (India) Limited has 19.004 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.528% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.147%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.121%. This tells us they're good at keeping money after all costs.

Return on Investments

Nath Bio-Genes (India) Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.069%.

Stock Prices

Nath Bio-Genes (India) Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $183.6, while its low point bottomed out at $174.8. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Nath Bio-Genes (India) Limited's stock market.

Profitability Ratios

NATHBIOGEN.NS profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 11.86% underscores its earnings before tax deductions. The effective tax rate stands at 3.94%, revealing its tax efficiency. The net income per EBT, 101.98%, and the EBT per EBIT, 80.76%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 14.69%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin11.86%
Effective Tax Rate3.94%
Net Income per EBT101.98%
EBT per EBIT80.76%
EBIT per Revenue14.69%

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 3.44, and free cash flow per share, 3.44, depict cash generation on a per-share basis. The cash per share value, 8.01, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.02, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share3.44
Free Cash Flow per Share3.44
Cash per Share8.01
Operating Cash Flow Sales Ratio0.02
Free Cash Flow to Operating Cash Flow Ratio1.00

Debt and Leverage Ratios

An interest coverage of 5.13 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Interest Coverage5.13

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -9.43%, indicates top-line expansion, while the gross profit growth, -9.84%, reveals profitability trends. EBIT growth, -45.28%, and operating income growth, -45.28%, offer insights into operational profitability progression. The net income growth, -220.98%, showcases bottom-line expansion, and the EPS growth, -220.96%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-9.43%
Gross Profit Growth-9.84%
EBIT Growth-45.28%
Operating Income Growth-45.28%
Net Income Growth-220.98%
EPS Growth-220.96%
EPS Diluted Growth-220.96%
Weighted Average Shares Growth0.01%
Weighted Average Shares Diluted Growth0.01%
Dividends per Share Growth-0.01%
Operating Cash Flow Growth1431.76%
Free Cash Flow Growth62.14%
10-Year Revenue Growth per Share70.22%
5-Year Revenue Growth per Share29.85%
3-Year Revenue Growth per Share20.72%
10-Year Operating CF Growth per Share1.01%
5-Year Operating CF Growth per Share132.43%
3-Year Operating CF Growth per Share177.51%
10-Year Net Income Growth per Share-582.77%
5-Year Net Income Growth per Share-304.63%
3-Year Net Income Growth per Share-275.20%
10-Year Shareholders Equity Growth per Share694.03%
5-Year Shareholders Equity Growth per Share3.25%
3-Year Shareholders Equity Growth per Share6.76%
Receivables Growth-8.47%
Inventory Growth-2.63%
Asset Growth-6.03%
Book Value per Share Growth-11.64%
Debt Growth-3.74%
R&D Expense Growth-2.94%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.64, and the price to book ratio, 0.64, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.16, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 59.37, and price to operating cash flows, 59.37, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.64
Price to Book Ratio0.64
Price to Sales Ratio1.16
Price Cash Flow Ratio59.37
Price Earnings to Growth Ratio-0.04
Enterprise Value Multiple7.10
Price Fair Value0.64
Price to Operating Cash Flow Ratio59.37
Price to Free Cash Flows Ratio59.37
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Nath Bio-Genes (India) Limited (NATHBIOGEN.NS) on the NSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 9.596 in 2024.

What is the ticker symbol of Nath Bio-Genes (India) Limited stock?

The ticker symbol of Nath Bio-Genes (India) Limited stock is NATHBIOGEN.NS.

What is company IPO date?

IPO date of Nath Bio-Genes (India) Limited is 2014-01-28.

What is company current share price?

Current share price is 204.350 INR.

What is stock market cap today?

The market cap of stock today is 3883467400.000.

What is PEG ratio in 2024?

The current -0.043 is -0.043 in 2024.

What is the number of employees in 2024?

In 2024 the company has 433.